Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Melatonin in osteosarcoma: an effective drug?

A Panzer1

  • 1Department of Physiology, University of Pretoria, South Africa.

Medical Hypotheses
|June 1, 1997
PubMed
Summary

Melatonin, a pineal hormone, may protect against osteosarcoma. Declining melatonin during puberty may coincide with increased bone cancer risk in adolescents.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Crisis-like Seizure Exacerbations in NPRL3-related Epilepsy: Phenotypic Features and Treatment Outcomes.

Neuropediatrics·2025
Same author

Clinical presentation, MR imaging and outcome in children with myelin oligodendrocyte glycoprotein antibody-negative acute disseminated encephalomyelitis.

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society·2025
Same author

Learning chronobiology by improving Wikipedia.

Journal of biological rhythms·2012
Same author

The central noradrenergic system: an overview.

African journal of psychiatry·2009
Same author

The neuroendocrinological sequelae of stress during brain development: the impact of child abuse and neglect.

African journal of psychiatry·2009
Same author

Scientific letter central role of the carbonic acid/bicarbonate buffer system in acid-base homeostasis.

East African medical journal·2007

Area of Science:

  • Endocrinology
  • Oncology
  • Pediatric Medicine

Background:

  • Melatonin, a pineal indole amine, exhibits oncostatic properties against various neoplasms.
  • Melatonin levels naturally decrease during puberty, coinciding with increased bone growth and osteosarcoma incidence.
  • Osteosarcoma typically affects the long bones of the leg in the 10-14-year age group.

Purpose of the Study:

  • To investigate the potential role of decreasing melatonin levels during puberty in the age-related incidence of osteosarcoma.
  • To explore melatonin's potential as an adjunct therapy in osteosarcoma treatment.

Main Methods:

  • Observational analysis of melatonin levels and osteosarcoma incidence during puberty.
  • Review of melatonin's pharmacological properties in cancer treatment.

Main Results:

  • A hypothesized link exists between declining melatonin and increased osteosarcoma risk during puberty.
  • Melatonin is non-toxic and can enhance chemotherapy efficacy while reducing side effects.

Conclusions:

  • The decline in melatonin during puberty may contribute to the characteristic age distribution of osteosarcoma.
  • Melatonin shows promise as an adjuvant therapy to improve osteosarcoma treatment outcomes.

Related Experiment Videos